These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current status of percutaneous coronary intervention with drug-eluting stents in Asia. Park SJ, Kim YH. Circulation; 2008 Dec 16; 118(25):2730-7. PubMed ID: 19106397 [No Abstract] [Full Text] [Related]
3. Coronary stents: current status. Garg S, Serruys PW. J Am Coll Cardiol; 2010 Aug 31; 56(10 Suppl):S1-42. PubMed ID: 20797502 [Abstract] [Full Text] [Related]
4. Coronary artery restenosis: a paradigm of current treatment approaches. Kiernan TJ, Kiernan GD, Yan BD. Minerva Cardioangiol; 2009 Feb 31; 57(1):77-94. PubMed ID: 19202520 [Abstract] [Full Text] [Related]
5. Coronary stents: looking forward. Garg S, Serruys PW. J Am Coll Cardiol; 2010 Aug 31; 56(10 Suppl):S43-78. PubMed ID: 20797503 [Abstract] [Full Text] [Related]
13. Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior. Celik T, Iyisoy A, Yuksel UC, Isik E. Int J Cardiol; 2009 Jan 09; 131(2):269-70; author reply 271-2. PubMed ID: 17692947 [Abstract] [Full Text] [Related]
14. Bifurcation stenting: current strategies and new devices. Latib A, Colombo A, Sangiorgi GM. Heart; 2009 Mar 09; 95(6):495-504. PubMed ID: 18812408 [Abstract] [Full Text] [Related]
15. Vasoconstriction and coronary artery spasm after drug-eluting stent placement. Togni M, Eberli FR. J Invasive Cardiol; 2006 Dec 09; 18(12):593. PubMed ID: 17197708 [No Abstract] [Full Text] [Related]
16. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial. Bangalore S, Khianey S, Messerli FH. Am J Cardiol; 2008 Apr 01; 101(7):1068. PubMed ID: 18359335 [No Abstract] [Full Text] [Related]
17. Left main coronary artery stenting: crossing the Rubicon. Alfonso F. J Am Coll Cardiol; 2009 May 12; 53(19):1769-72. PubMed ID: 19422983 [No Abstract] [Full Text] [Related]
18. Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response. Li JJ, Gao RL. Chin Med J (Engl); 2009 Mar 20; 122(6):732-5. PubMed ID: 19323943 [No Abstract] [Full Text] [Related]
19. Coronary stenting challenges: technique, design and pharmacology. Linnemeier TJ. J Invasive Cardiol; 1999 Jan 20; 11(1):43-6; discussion 46. PubMed ID: 10745437 [No Abstract] [Full Text] [Related]
20. Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: current status and future perspective. Li XJ, Rha SW, Wani SP, Wang L, Poddar KL, Oh DJ. Chin Med J (Engl); 2009 Sep 20; 122(18):2174-9. PubMed ID: 19781306 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]